This site requires JavaScript to be enabled to work properly. Please modify your settings or use a different browser to continue

      

You are now leaving a GSK Israel Website.

You are now leaving a GSK Israel Website. By clicking this link, you will be taken to a website that is not owned or controlled by GSK Israel.

Continue

Go back

209 results

Homepage

GSKpro is exclusively created for healthcare professionals to provide GSK product related information, services and support.

Search Results

GlaxoSmithKline (GSK) UK healthcare professional website search results.

GSKpro XX | Product Information for Healthcare Professionals

GSKpro is exclusively created for healthcare professionals to provide GSK product related information, services and support.

Triumeq

dolutegravir/abacavir/lamivudine <br>HIV

Why Use BENLYSTA

Why Use BENLYSTA

Special considerations

Patients who are not recommended to receive BENLYSTA once-weekly subcutaneous injection, use in pregnancy and lactation.

Safety

BENLYSTA once-weekly subcutaneous injection, safety

Storage and disposal

Storage and disposal instruction for BENLYSTA Pre-filled Pen for once-weekly subcutaneous injection

Administration

Administration of BENLYSTA once-weekly subcutaneous injection

Disease Activity

Effect of BENLYSTA once-weekly subcutaneous injection on disease activity reduction in patients with high disease activity

How BENLYSTA works

BENLYSTA selectively inhibits BLyS, an important factor in SLE

Fatigue

BENLYSTA once-weekly subcutaneous injection – Significant improvement in fatigue

Corticosteroids

BENLYSTA once-weekly subcutaneous injection – reduction in corticosteroid use

Clinical Trial Information

Overview of BLISS-SC clinical trial

About SRI

Description of SLE Responder Index and its components

Efficacy

Overview of key efficacy points of BENLYSTA once-weekly subcutaneous injection

Patient profile: Amy

Detailed description of a patient with lupus and chronic fatigue presentation, including manifestation and laboratory assessment.

Patient profile: Tina

BENLYSTA Patient Profile

Patient profile: Sara

Detailed description of a patient with mucocutaneous and musculoskeletal lupus, including clinical manifestation and laboratory assessment.

Patient profile: Zoe

Detailed description of a patient with mucocutaneous and musculoskeletal lupus, including clinical manifestation and laboratory assessment.

Patient Identification

Characteristics of patients eligible for BELYSTA once-weekly subcutaneous injection, high disease activity characteristics, clinical manifestations, concomitant medications

GSKpro/products/Benlysta/Identifying Patients

GSKpro is exclusively created for healthcare professionals to provide GSK product related information, services and support.

GSKpro/products/Benlysta/Dosing and Administration

GSKpro is exclusively created for healthcare professionals to provide GSK product related information, services and support.

GSKpro/products/Benlysta/Safety Profile

GSKpro is exclusively created for healthcare professionals to provide GSK product related information, services and support.

GSKpro/products/Benlysta/Organ Damage

GSKpro is exclusively created for healthcare professionals to provide GSK product related information, services and support.

GSKpro/products/Benlysta/Efficacy

GSKpro is exclusively created for healthcare professionals to provide GSK product related information, services and support.

GSKpro/products/Benlysta/home

GSKpro is exclusively created for healthcare professionals to provide GSK product related information, services and support.

GSKpro/products/Benlysta/Study Design

GSKpro is exclusively created for healthcare professionals to provide GSK product related information, services and support.

Trelegy Ellipta – Asthma - treating Asthma

Discover how to use Trelegy Ellipta to treat patients with asthma

Nucala

mepolizumab<br> Respiratory

Anoro Ellipta

umeclidinium/vilanterol<br> Respiratory

GSKpro XX | Product Information for Healthcare Professionals

GSKpro is exclusively created for healthcare professionals to provide GSK product related information, services and support.

Invasive Meningococcal Disease (IMD) | BEXSERO

GSKpro is exclusively created for healthcare professionals to provide GSK product related information, services and support.

Breathlessness

Trelegy Ellipta is a Triple Therapy for appropriate patients with COPD.

Quality of Life

Page providing information about Quality of Life for Trelegy fulfill study.

Presentations

GSKpro is exclusively created for healthcare professionals to provide GSK product related information, services and support.

Quality of Life

Health-related QoL efficacy results for TRELEGY Ellipta

Lung Function

Lung Function efficacy results for TRELEGY Ellipta

Dosing & Device

GSKpro is exclusively created for healthcare professionals to provide GSK product related information, services and support.

Safety

GSKpro is exclusively created for healthcare professionals to provide GSK product related information, services and support.

Trelegy Ellipta 2022

A page on Trelegy Ellipta Webinar - 2022

GSKpro/products/Benlysta/ home

GSKpro is exclusively created for healthcare professionals to provide GSK product related information, services and support.

Tivicay

dolutegravir <br>HIV

benlysta

Belimumab <br> Systemic Lupus Erythematous

Bexsero

Meningococcal Group B Vaccine (rDNA, component, absorbed) <br> Vaccines

Dovato

dolutegravir/lamivudine</br> HIV

Ana

Patient Stories

GSKpro is exclusively created for healthcare professionals to provide GSK product related information, services and support.

Dosing and administration

GSKpro is exclusively created for healthcare professionals to provide GSK product related information, services and support.

Safety

GSKpro is exclusively created for healthcare professionals to provide GSK product related information, services and support.

Real-World Evidence

GSKpro is exclusively created for healthcare professionals to provide GSK product related information, services and support.

Resources

GSKpro is exclusively created for healthcare professionals to provide GSK product related information, services and support.

Bexsero

GSKpro is exclusively created for healthcare professionals to provide GSK product related information, services and support.

Exacerbations

Exacerbation efficacy results for TRELEGY Ellipta.

Efficacy

GSKpro is exclusively created for healthcare professionals to provide GSK product related information, services and support.

Trelegy Ellipta – Asthma – dosing & device

Discover Trelegy Ellipta dosing and device information for asthma patients

Trelegy Ellipta – Asthma – efficacy

Find out about Trelegy Ellipta’s efficacy data in asthma patients

Trelegy Ellipta – Asthma – mode of action

Find out about Trelegy Ellipta’s mode of action in asthma patients

Trelegy Ellipta – Asthma - Identifying patients

Find how to identify asthma patients appropriate for treatment with Trelegy Ellipta

Trelegy Ellipta - Asthma - Safety

Learn about Trelegy Ellipta’s safety profile for asthma patients

Trelegy Ellipta

fluticasone furoate/umeclidinium/vilanterol <br>Respiratory

Avamys

fluticasone furoate<br>Respiratory

Duodart

0.5 mg Dutasteride and 0.4 mg Tamsulosin hydrochloride<br>Urology

Seretide

salmeterol xinafoate / fluticasone propionate<br>Respiratory

Zinnat

cefuroxime axetil<br>Anti-infectives

Augmentin

amoxicillin-clavulanate<br>Anti-infectives

Volibris

Ambrisentan<br>Pulmonology

Wellbutrin

bupropion hydrochloride<br>Psychiatry

Relvar Ellipta

fluticasone furoate / vilanterol <br>Respiratory

Incruse Ellipta

Umeclidinium <br>Respiratory

Safety | SHINGRIX (herpes zoster vaccine, recombinant, adjuvanted)

SHINGRIX prescribing information for UK healthcare professionals

Vaccinate with SHINGRIX | SHINGRIX (herpes zoster vaccine, recombinant, adjuvanted)

SHINGRIX prescribing information for UK healthcare professionals

Efficacy & Safety Data / Shingrix ▼

Shingrix ▼ efficacy and safety data in immunocompromised patients for UK healthcare professionals

Shingles Burden of disease

shingles burden of disease information for UK healthcare professionals

Home | SHINGRIX (herpes zoster vaccine, recombinant, adjuvanted)

SHINGRIX prescribing information for UK healthcare professionals

Scientific Rationale | SHINGRIX (herpes zoster vaccine, recombinant, adjuvanted)

SHINGRIX prescribing information for UK healthcare professionals

Efficacy | SHINGRIX (herpes zoster vaccine, recombinant, adjuvanted)

SHINGRIX prescribing information for UK healthcare professionals

PHN-Efficacy | SHINGRIX (herpes zoster vaccine, recombinant, adjuvanted)

SHINGRIX prescribing information for UK healthcare professionals

TRELEGY Ellipta

Trelegy Ellipta in COPD and ASTHMA

GSK Pro Products Webinar

GSK Pro Products Webinar

ERS Conference webinars

GSKpro is exclusively created for healthcare professionals to provide GSK product related information, services and support.

Relvar COPD Efficacy

Relvar▼ Ellipta 92/22 mcg summary of efficacy in COPD – including the latest data on efficacy, exacerbations, improvements in lung function and COPD-related health status

Webinars

GSKpro is exclusively created for healthcare professionals to provide GSK product related information, services and support.

Relvar Asthma Efficacy

Relvar Ellipta summary of efficacy in asthma – including the latest data on efficacy against symptoms and exacerbations, improvements in Quality of Life and lung function

Home

Discover the efficacy of Trelegy in reducing exacerbations

No results. Why not try:

  • Checking the spelling of the search term
  • Trying a different search term
  • Resetting or revising the filter settings (if you used filters to do this search)

show more